Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1385 of 5804
-
New MRI dye aims to sharpen prostate cancer detection
Diagnosis TerminatedThe fundamental aim of this study is to show that the novel contrast agent Gadopiclenol (Elucirem), with its high relaxivity, facilitates increased contrast enhancement and improved differentiation of clinically significant prostate cancer on Prostate MRI, as categorized by the P…
Phase: PHASE4 • Sponsor: Columbia University • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
New drug combo takes on tough lung cancer
Disease control OngoingThis study is open to adults with extensive stage small cell lung cancer. The study is in people with advanced cancer that had previously received platinum-based chemotherapy and are eligible to receive a single agent chemotherapy treatment. The purpose of this study is to find …
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Home workouts with live coaching could ease cancer side effects
Symptom relief Recruiting nowBackground Many people with cancer face ongoing problems from their disease and treatments, like fatigue, reduced physical fitness, feeling anxious or down, and neuropathy. While exercise might help with these problems, most studies did not focus on tailoring exercise to address…
Phase: NA • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Mental strategy training may quiet a key brain region linked to Alzheimer's risk
Symptom relief CompletedThis study aims to reduce hippocampal activity in people at high risk of developing Alzheimer's disease (AD) and aims to examine whether this improves their episodic memory performance. We apply mental strategy trainings with strategies extracted from our previous study that appl…
Phase: NA • Sponsor: Jessica Peter • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Shockwave therapy may improve stent success in hardened leg arteries
Disease control Recruiting nowThis study is an investigator-initiated, prospective, single-center, 1:1 randomized pilot study. The trial evaluates the safety and efficacy of intravascular lithotripsy in comparison to standard lesion preparation using standard and/or high-pressure balloon angioplasty in patie…
Phase: NA • Sponsor: University of Leipzig • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Double-Dose HIV drug shows promise for Co-Infected patients
Disease control CompletedA5406 hypothesized that dolutegravir (DTG) 50 mg taken twice daily provides adequate exposures to maintain viral suppression when dosed with rifapentine (RPT) 1200 mg for HIV-associated tuberculosis (TB).
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
MRI scans reveal hidden effects of opioids on unborn babies
Knowledge-focused ENROLLING_BY_INVITATIONThe goal of this observational study is to learn about the long term effects of prenatal opioid exposure. The main objectives are: * Long term goal: to improve the safety and efficacy of maternal Opioid Use Disorder (OUD) and eliminate neonatal opioid withdrawal syndrome (NOWS) …
Sponsor: Senthil Sadhasivam • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Tailored brain zaps may boost stroke recovery
Symptom relief Recruiting nowThe objective of this study was to determine the effects of protocols of repetitive transcranial magnetic stimulation (rTMS) therapy based on the functional reserve of each hemiplegic stroke patient in subacute phase, compared to conventional low-frequency rTMS therapy on contral…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New hope for rare liver cancer: drug duo targets tumor fuel
Disease control Recruiting nowThe purpose of this study is to determine whether the combination of subcutaneous DRP-104 in combination with intravenous Durvalumab is safe and yields a clinically compelling antitumor activity measured as based on objective response rate (ORR, assessed by RECIST 1.1). Secondary…
Phase: PHASE1, PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Why does immunotherapy fail in some bowel cancer patients? new study aims to find out
Knowledge-focused Recruiting nowThe Keynote 117 phase III trial demonstrated the superiority of pembrolizumab (anti-PD1 monoclonal antibody) versus chemotherapy +/- targeted therapy in first-line treatment of dMMR/MSI metastatic colorectal cancer (mCRC). However, primary resistance to pembrolizumab was observed…
Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Heart valve fix gets a High-Tech upgrade: Self-Centering catheter tested in humans
Symptom relief CompletedVIVHEART EasyCross™ is a self-centering device for inserting a guidewire through a heart valve. It consists in a temporary catheter inserted into an artery with a terminal part able to expand a distal structure with 6 arms ("basket") to allow distancing of the catheter from the v…
Phase: NA • Sponsor: Vivheart s.r.l. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Engineered immune cells take on lupus in tiny trial
Disease control OngoingThis is a Phase II study to evaluate the safety, tolerability and manufacturing feasibility of Descartes-08 CAR T-cells in patients with Systematic Lupus erythematosus (SLE).
Phase: PHASE2 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart pressure check during common procedure could unmask hidden heart failure
Disease control OngoingThis study examines whether measuring blood pressure inside the left upper chamber of the heart during a procedure to treat an irregular heartbeat called atrial fibrillation can help identify patients who would benefit from heart failure medications. During atrial fibrillation ab…
Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug shows promise for NF1 skin tumors in early trial
Disease control Recruiting nowThis is a Phase 1/2a, open-label, non-randomized, multi-dose study of mirdametinib monotherapy in adults with NF1 and cNF. In both Phases of the study, participation in the study will comprise three periods: screening, treatment and post-study safety follow-up to be performed at…
Phase: PHASE1, PHASE2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Lab-Grown cells offer hope for transplant complication
Disease control Recruiting nowA study to evaluate the safety and preliminary efficacy of iMSC in subjects with SR-aGVHD
Phase: NA • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New weapon against tough ovarian cancer enters human testing
Disease control Recruiting nowThis phase 1 study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of CUSP06 in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors.
Phase: PHASE1 • Sponsor: OnCusp Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New drug BL-M07D1 targets multiple HER2 cancers in early trial
Disease control Recruiting nowThe objective of this study is to evaluate the safety, tolerability, and efficacy of BL-M07D1 in patients with HER2 expressing advanced tumors.
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug combo targets rare genetic tumor marker in observational trial
Disease control Recruiting nowThis is a prospective, multicenter, single-arm, non-interventional and observational J-PMS conducted by the central registration system and operated in Electronic data capture.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New At-Home devices show promise for phantom limb pain relief
Symptom relief Completed86-87% of people who have had an amputation still feel pain in the limb that has been amputated - Phantom limb pain (PLP). Sensory retraining is a form of treatment for PLP where a special form of electrical stimulation is delivered to the residual limb. The theory is that this …
Phase: NA • Sponsor: Teesside University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Brain training with a virtual coach may fight chemo fog
Symptom relief Recruiting nowInvestigator propose the first French randomized comparative study to assess the efficacy of a remotely supervised online cognitive stimulation program, compared to an unsupervised online cognitive exercise intervention, in reducing cognitive complaints in localized breast cancer…
Phase: NA • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Jun 26, 2026 18:57 UTC